Managed Account Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Managed Account Advisors’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$5.75M	Buy	252,149 +3,512	+1%	+$69.9K	﹤0.01%	1358
2015 Q1	$3.78M	Buy	248,637 +248,498	+178,776%	+$3.23M	﹤0.01%	1561
2014 Q4	$2K	Sell	139 -208,008	-100%	-$2.38M	﹤0.01%	2692
2014 Q3	$2.36M	Buy	208,147 +18,020	+9%	+$206K	﹤0.01%	1736
2014 Q2	$2.3M	Buy	190,127 +7,063	+4%	+$83.4K	﹤0.01%	1727
2014 Q1	$2.13M	Buy	183,064 +16,397	+10%	+$278K	﹤0.01%	1716
2013 Q4	$2.95M	Buy	+166,667	New	+$2.8M	﹤0.01%	1555

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Managed Account Advisors's MNTA Position: Q2 2015 in Review

Managed Account Advisors increased its Momenta Pharmaceuticals, Inc. (MNTA) stake by 1.4% in Q2 2015, buying an estimated $69.9K and bringing the position to 252,149 shares worth $5.75M. The position accounts for ﹤0.01% of the portfolio, ranked #1358.

Managed Account Advisors first reported a position in MNTA in Q4 2013 and has held it in 7 quarters since. 162 funds tracked by Wall St. Rank hold MNTA as of Q2 2015.

Managed Account Advisors held 252,149 shares of Momenta Pharmaceuticals, Inc. worth $5.75M as of Q2 2015.
Managed Account Advisors bought 3,512 Momenta Pharmaceuticals, Inc. shares in Q2 2015, an estimated $69.9K.
Momenta Pharmaceuticals, Inc. made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #1358 holding.
Managed Account Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2013 and has held it in 7 quarters since.
162 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.